Preeclampsia in Fetal Medicine

Cahit Birdir; Sevgi Tercanli

doi:10.1055/s-0043-121859

Ultraschall in der Medizin - European Journal of Ultrasound, Inhaltsverzeichnis

Ultraschall Med 2017; 38(06): 589-590
DOI: 10.1055/s-0043-121859

Editorial

Preeclampsia in Fetal Medicine

Präeklampsie-Screening in der Feto-Maternalen Medizin

Autor*innen

Cahit Birdir
Sevgi Tercanli

Abstract

Volltext

Referenzen

References
1 World Health Organization. Make every mother and child count: World Health Report, 2005. Geneva, Switzerland: World Health Or- ganization; 2005
2 Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137
3 National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: RCOG Press; 2010
4 Wright D, Akolekar R, Syngelaki A. et al. A competing risks model in early screening for preeclampsia. Fetal Diagn Ther 2012; 32: 171-178
5 Akolekar R, Syngelaki A, Poon L. et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013; 33: 8-15
6 Wright D, Syngelaki A, Akolekar R. et al. Competing risks model in screening for preeclampsia by maternal char- acteristics and medical history. Am J Obstet Gynecol 2015; 213: 62.e1-62.e10
7 Gallo DM, Poon LC, Akolekar R. et al. Prediction of preeclampsia by uterine artery Doppler at 20–24 weeks' gestation. Fetal Diagn Ther 2013; 34: 241-247
8 Poon LC, Karagiannis G, Leal A. et al. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks. Ultrasound Obstet Gynecol 2009; 34: 497-502 doi: 10.1002/uog.7439
9 Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenat Diagn 2011; 31: 3-6
10 Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn 2014; 34: 618-627
11 Rolnik DL, Wright D, Poon LC. et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med 2017; 377: 613-622 doi: 10.1056/NEJMoa1704559. Epub 2017 Jun 28.
12 Poon LC, Wright D, Rolnik DL. et al. ASPRE trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol 2017;